Skip to content
10-Q

Quarterly Report

Icagen, Inc.

0001213900-18-006641

← back to feed
Filed
May 21, 2018 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2018 · May 20, 2018 6.39M sh
Current Liabilities Q1 2018 · Mar 31, 2018 $5.67M
Current Liabilities Q1 2018 · Dec 31, 2017 $4.97M
Total Liabilities Q1 2018 · Mar 31, 2018 $24.3M
Total Liabilities Q1 2018 · Dec 31, 2017 $23.31M
Current Assets Q1 2018 · Mar 31, 2018 $2.94M
Current Assets Q1 2018 · Dec 31, 2017 $4.79M
Total Assets Q1 2018 · Mar 31, 2018 $12.56M
Total Assets Q1 2018 · Dec 31, 2017 $14.64M
Cost Of Revenue Q1 2018 · Mar 31, 2018 $2.65M
Cost Of Revenue Q1 2018 · Mar 31, 2017 $2.94M
Net Income Q1 2018 · Dec 31, 2017 −$6.11M
Net Income Q1 2018 · Mar 31, 2017 −$805.73K
Capex Q1 2018 · Mar 31, 2017 $354.95K
Operating Cash Flow Q1 2018 · Mar 31, 2017 −$2.75M
Cash And Equivalents restated Q1 2018 · Mar 31, 2017 $2.76M
Cash And Equivalents restated Q1 2018 · Dec 31, 2016 $4.94M
Sga Expense Q1 2018 · Mar 31, 2017 $3.1M
Operating Income Q1 2018 · Mar 31, 2017 −$655.91K
Gross Profit Q1 2018 · Mar 31, 2017 $2.88M